Oxford Biomedica (LON:OXB) Shares Cross Above 200 Day Moving Average of $203.60

Oxford Biomedica plc (LON:OXBGet Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 203.60 ($2.56) and traded as high as GBX 333.50 ($4.19). Oxford Biomedica shares last traded at GBX 331 ($4.16), with a volume of 185,479 shares.

Wall Street Analyst Weigh In

Separately, Numis Securities restated a “hold” rating and set a GBX 180 ($2.26) price objective on shares of Oxford Biomedica in a research note on Wednesday, March 20th.

View Our Latest Stock Analysis on OXB

Oxford Biomedica Stock Performance

The company has a debt-to-equity ratio of 57.10, a current ratio of 3.32 and a quick ratio of 1.67. The stock has a fifty day moving average price of GBX 234.72 and a two-hundred day moving average price of GBX 205.25. The company has a market cap of £323.50 million, a P/E ratio of -505.47 and a beta of 1.03.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Recommended Stories

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.